EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
418,252
Share change
-92,470
Total reported value
$1,379,000
Price per share
$3.30
Number of holders
14
Value change
-$297,500
Number of buys
7
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q4 2015

As of 31 Dec 2015, EVOKE PHARMA INC - COM (EVOK) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 418,252 shares. The largest 10 holders included Opaleye Management Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Knoll Capital Management, LP, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, A.R.T. Advisors, LLC, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), and BANK OF AMERICA CORP /DE/. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.